Cargando…

Charged particle exclusive analysis of central Ar+KCl and Ar+Pb reactions at 1.8 and 0.8 GeV/u

Detalles Bibliográficos
Autores principales:	Ströbele, H, Brockmann, R, Harris, J W, Riess, F, Sandoval, A, Stock, Reinhard, Wolf, K L, Pugh, Howel G, Schröder, L S, Renfordt, R E, Tittel, K, Maier, M
Lenguaje:	eng
Publicado:	1982
Materias:	Nuclear Physics
Acceso en línea:	http://cds.cern.ch/record/140738

Ejemplares similares

Compression effects in relativistic nucleus-nucleus collisions
por: Stock, Reinhard, et al.
Publicado: (1982)

(4aR,8aR)-2,3-Diphenyl-4a,5,6,7,8,8a-hexahydroquinoxaline
por: Wang, Guo-Xi, et al.
Publicado: (2008)

rac-(4aR,8aR)-2,3-Diphenyl-4a,5,6,7,8,8a-hexahydroquinoxaline
por: Chen, Fang, et al.
Publicado: (2008)

$^{43}$Ar and $^{44}$Ar
por: Hudis, J, et al.
Publicado: (1970)

$^{43}Ar$ and $^{44}Ar$
por: Hudis, J, et al.
Publicado: (1970)

To Be(Ar) Or Not to Be(Ar) – Jones Dilemma?
por: Andrews, Nicholas A., et al.
Publicado: (2022)

System size scan of D meson RAA and vn using PbPb, XeXe, ArAr, and OO collisions
por: Noronha-Hostler, Jacquelyn
Publicado: (2020)

1-[(2R,4aR,8R,8aR)-8-Hydroxy-4a,8-dimethylperhydronaphthalen-2-yl]ethan-1-one
por: Tebbaa, Mohamed, et al.
Publicado: (2011)

Masses of 32Ar and 33Ar for fundamental tests
por: Blaum, K, et al.
Publicado: (2003)

The mass of $^{32}Ar$ and $^{33}Ar$ for fundamental tests
por: Blaum, K, et al.
Publicado: (2003)

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
por: Wüstmann, Neele, et al.
Publicado: (2023)

On atmospheric $^{39}Ar$ and $^{42}Ar$ abundance
por: Cennini, P, et al.
Publicado: (1995)

The HIF/PHF8/AR axis promotes prostate cancer progression
por: Tong, D, et al.
Publicado: (2016)

(±)-(4aR,5R,8S,8aR)-8-(tert-Butyldimethylsilyloxy)-2,5,8a-trimethyl-4a,5,8,8a-tetrahydronaphthalene-1,4-dione
por: Delling, Felix N., et al.
Publicado: (2013)

KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC
por: Wang, Hung-Jung, et al.
Publicado: (2018)

Determination of $^{44}Ar$(n,$\gamma$)$^{45}$Ar, and $^{46}$Ar(n,$\gamma$)$^{47}$Ar reaction rates by (d,p) transfer reactions
por: Sorlin, O, et al.
Publicado: (2002)

Ár njöt'i ar hai = El color de la tierra
Publicado: (2014)

AR Splicing Variants and Resistance to AR Targeting Agents
por: Kanayama, Mayuko, et al.
Publicado: (2021)

ARS Leptogenesis
por: Drewes, M., et al.
Publicado: (2017)

Ars melancholiae
por: Weiss, Silvius Leopold, 1686-1750
Publicado: (1994)

Ars Obstetrica
por: Armytage, V. B. Green
Publicado: (1930)

Ars Gynæcologica
por: Green-Armytage, V. B.
Publicado: (1930)

Ars Obstetrica
por: Umachigi, V. S.
Publicado: (1930)

Ars Longa
Publicado: (1893)

The decay of $^{31}$Ar
por: García-Borge, M J, et al.
Publicado: (1990)

(3aR,8aS,9S,9aR)-9-Hydroxyperhydrofuro[3,2-f]indolizin-6-one
por: Švorc, Ľubomír, et al.
Publicado: (2009)

Boutique neutrons advance (40)Ar/(39)Ar geochronology
por: Rutte, Daniel, et al.
Publicado: (2019)

(4aR*,8aS*)-2,3-Diphenyl-4a,5,6,7,8,8a-hexahydroquinoxaline
por: Chen, W., et al.
Publicado: (2012)

Crystal structure and Hirshfeld analysis of (1aS,3aR,4aS,5aR)-15-acetoxylinden-7(11),8-trieno-12,8-lactone
por: Lu, Qiang-Qiang, et al.
Publicado: (2022)

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
por: Sugiura, Masahiro, et al.
Publicado: (2020)

(2S,4aR,3S,8aR,9R,10R)-1,4-Diallyl-2,3-diphenylperhydroquinoxaline
por: Chen, Fang, et al.
Publicado: (2008)

StAR Protein Stability in Y1 and Kin-8 Mouse Adrenocortical Cells
por: Clark, Barbara J., et al.
Publicado: (2015)

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

The ArDM experiment
por: Haranczyk, M, et al.
Publicado: (2010)

(3aR,8aR)-2,2,6,6-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-1,3-dioxolo[4,5-e][1,3,2]dioxasilepine
por: Hijji, Yousef M., et al.
Publicado: (2008)

GABARAPL1 Promotes AR+ Prostate Cancer Growth by Increasing FL-AR/AR-V Transcription Activity and Nuclear Translocation
por: Su, Bing, et al.
Publicado: (2019)

AR mRNA stability is increased with AR-antagonist resistance via 3′UTR variants
por: Dart, D A, et al.
Publicado: (2019)

Ars medica mexicana
por: Pérez-Tamayo, Ruy

Pelagonius, Ars Veterinaria
por: Nutton, Vivian
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_21ak5g251chjhu7qv4opgnbkc2